Boston Scientific
Boston Scientific returns on capital
Annual and trailing 12-month returns on invested capital, equity and assets.
ROIC
% · Annual / TTM
ROCE
% · Annual / TTM
ROIIC
% · Annual / TTM
ROE
% · Annual / TTM
ROA
% · Annual / TTM
ROIC − WACC
Percentage points · Scenario
Quarterly data
| Fiscal period | Ended | ROIC% | ROCE% | ROIIC% | ROE% | ROA% | ROIC − WACCPercentage points |
|---|---|---|---|---|---|---|---|
| FY 2026 Q2 | Jun 30, 2026 | 11.12% | 11.05% | 37.29% | 15.52% | 8.46% | 3.4 pp |
| FY 2026 Q1 | Mar 31, 2026 | 10.5% | 10.13% | 48.31% | 14.83% | 8.42% | 2.8 pp |
| FY 2025 Q4 | Dec 31, 2025 | 9.31% | 10.14% | 61.02% | 12.6% | 6.96% | 1.6 pp |
| FY 2025 Q3 | Sep 30, 2025 | 9.32% | 9.96% | 19.71% | 12.66% | 6.89% | 1.6 pp |
| FY 2025 Q2 | Jun 30, 2025 | 8.46% | 9.27% | 9.51% | 11.71% | 6.35% | 0.8 pp |
| FY 2025 Q1 | Mar 31, 2025 | 7.57% | 8.53% | 6.43% | 9.64% | 5.27% | -0.1 pp |
| FY 2024 Q4 | Dec 31, 2024 | 7.01% | 8.24% | 4.96% | 9.03% | 4.95% | -0.7 pp |
| FY 2024 Q3 | Sep 30, 2024 | 7.23% | 8.15% | 27.57% | 9.06% | 4.96% | -0.5 pp |
| FY 2024 Q2 | Jun 30, 2024 | 7.6% | 8.16% | 86.74% | 9.48% | 5.16% | -0.1 pp |
| FY 2024 Q1 | Mar 31, 2024 | 7.39% | 8.14% | 49.06% | 9.35% | 5.09% | -0.3 pp |
| FY 2023 Q4 | Dec 31, 2023 | 7.04% | 7.96% | 39.8% | 8.52% | 4.71% | -0.7 pp |
| FY 2023 Q3 | Sep 30, 2023 | 5.35% | 7.47% | 28.58% | 6.53% | 3.72% | -2.4 pp |
| FY 2023 Q2 | Jun 30, 2023 | 4.15% | 6.37% | -5.45% | 4.85% | 2.77% | -3.5 pp |
| FY 2023 Q1 | Mar 31, 2023 | 4.19% | 6.1% | -7.32% | 4.89% | 2.77% | -3.5 pp |
| FY 2022 Q4 | Dec 31, 2022 | 4.09% | 5.82% | -8.26% | 3.75% | 2.16% | -3.6 pp |
| FY 2022 Q3 | Sep 30, 2022 | 4.35% | 5.07% | 4.25% | — | 2.05% | -3.4 pp |
| FY 2022 Q2 | Jun 30, 2022 | 4.82% | 5.26% | — | — | 2.79% | -2.9 pp |
| FY 2022 Q1 | Mar 31, 2022 | 4.76% | 4.66% | — | — | 2.56% | -2.9 pp |
| FY 2021 Q4 | Dec 31, 2021 | 4.98% | 4.36% | — | — | 3.3% | -2.7 pp |
| FY 2021 Q3 | Sep 30, 2021 | 4.21% | 3.86% | — | — | 3.69% | -3.5 pp |
| FY 2021 Q2 | Jun 30, 2021 | — | 1.74% | — | — | 1.88% | — |
| FY 2021 Q1 | Mar 31, 2021 | — | 0.54% | — | — | 0.82% | — |
| FY 2020 Q4 | Dec 31, 2020 | — | -0.3% | — | — | -0.27% | — |
| FY 2020 Q3 | Sep 30, 2020 | — | 0.32% | — | — | 12.86% | — |
| FY 2020 Q2 | Jun 30, 2020 | — | 2.83% | — | — | 14.46% | — |
| FY 2020 Q1 | Mar 31, 2020 | — | 4.94% | — | — | 15.9% | — |
| FY 2019 Q4 | Dec 31, 2019 | — | 7.33% | — | — | 18.23% | — |
| FY 2019 Q3 | Sep 30, 2019 | — | 8.61% | — | — | 4.63% | — |
| FY 2019 Q2 | Jun 30, 2019 | — | 9.51% | — | — | 6.36% | — |
| FY 2019 Q1 | Mar 31, 2019 | — | 9.78% | — | — | 8.36% | — |
| FY 2018 Q4 | Dec 31, 2018 | — | 10.34% | — | — | 8.35% | — |
| FY 2018 Q3 | Sep 30, 2018 | 5.37% | 10.34% | — | — | 3.43% | -2.3 pp |
| FY 2018 Q2 | Jun 30, 2018 | 4.81% | 10.32% | — | — | 2.74% | -2.9 pp |
| FY 2018 Q1 | Mar 31, 2018 | 1.26% | 9.26% | — | — | 0.6% | -6.4 pp |
| FY 2017 Q4 | Dec 31, 2017 | 1.18% | 9.21% | — | — | 0.56% | -6.5 pp |
| FY 2017 Q3 | Sep 30, 2017 | — | 7.76% | — | — | 4.64% | — |
| FY 2017 Q2 | Jun 30, 2017 | — | 7.5% | — | — | 4.35% | — |
| FY 2017 Q1 | Mar 31, 2017 | — | 3.5% | — | — | 2.44% | — |
| FY 2016 Q4 | Dec 31, 2016 | — | 2.96% | — | — | 1.92% | — |
| FY 2016 Q3 | Sep 30, 2016 | — | 0.23% | — | — | 0.45% | — |
| FY 2016 Q2 | Jun 30, 2016 | — | -4.09% | — | — | -1.97% | — |
| FY 2016 Q1 | Mar 31, 2016 | — | -0.4% | — | — | -0.21% | — |
| FY 2015 Q4 | Dec 31, 2015 | — | -2.19% | — | — | -1.36% | — |
| FY 2015 Q3 | Sep 30, 2015 | — | -3.55% | — | — | -2.27% | — |
| FY 2015 Q2 | Jun 30, 2015 | — | -1.24% | — | — | -0.92% | — |
| FY 2015 Q1 | Mar 31, 2015 | — | -3.3% | — | — | -1.54% | — |
| FY 2014 Q4 | Dec 31, 2014 | — | -2.08% | — | — | -0.71% | — |
| FY 2014 Q3 | Sep 30, 2014 | — | 2.13% | — | — | 1.71% | — |
| FY 2014 Q2 | Jun 30, 2014 | — | 2.44% | — | — | 1.43% | — |
| FY 2014 Q1 | Mar 31, 2014 | — | 4.34% | — | — | 2.21% | — |
| FY 2013 Q4 | Dec 31, 2013 | — | 0.8% | — | — | -0.72% | — |
| FY 2013 Q3 | Sep 30, 2013 | — | 0.73% | — | — | -0.99% | — |
| FY 2013 Q2 | Jun 30, 2013 | — | -3.84% | — | — | -4.75% | — |
| FY 2013 Q1 | Mar 31, 2013 | — | -25.37% | — | — | -23.9% | — |
| FY 2012 Q4 | Dec 31, 2012 | — | -22.19% | — | — | -21.16% | — |
| FY 2012 Q3 | Sep 30, 2012 | — | -21.99% | — | — | -20.95% | — |
| FY 2012 Q2 | Jun 30, 2012 | — | -17.07% | — | — | -16.33% | — |
| FY 2012 Q1 | Mar 31, 2012 | — | 3.93% | — | — | 2.35% | — |
| FY 2011 Q4 | Dec 31, 2011 | 3.9% | 4.64% | — | — | 2.03% | -3.8 pp |
| FY 2011 Q3 | Sep 30, 2011 | 5.01% | 5.53% | — | — | 2.59% | -2.7 pp |
| FY 2011 Q2 | Jun 30, 2011 | 5.49% | 5.95% | — | — | 2.77% | -2.2 pp |
| FY 2011 Q1 | Mar 31, 2011 | 5.26% | 5.77% | — | — | 2.54% | -2.4 pp |
| FY 2010 Q4 | Dec 31, 2010 | — | -3.15% | — | — | -4.5% | — |
| FY 2010 Q3 | Sep 30, 2010 | — | -10.5% | — | — | -9.75% | — |
| FY 2010 Q2 | Jun 30, 2010 | — | -11.39% | — | — | -10.81% | — |
| FY 2010 Q1 | Mar 31, 2010 | — | — | — | — | — | — |
| FY 2009 Q4 | Dec 31, 2009 | — | — | — | — | — | — |
| FY 2009 Q3 | Sep 30, 2009 | — | — | — | — | — | — |
| FY 2009 Q2 | Jun 30, 2009 | — | — | — | — | — | — |
Sources and calculations
Financial inputs from company filings. Last checked Oct 18, 2026. A dash means missing inputs or an undefined calculation.
Period changes use the preceding fiscal quarter or year. Percentage changes divide by the absolute prior value; a zero or missing baseline has no percentage change. Percentage metrics show changes in percentage points.
Quarterly returns use trailing 12-month earnings and period-end balances averaged with the same fiscal quarter one year earlier. NOPAT uses the reported effective tax rate only when pretax profit is positive and the rate is between 0 and 100%. WACC starts at 7.7%, rounded from the US nonfinancial market · generic proxy benchmark in NYU Stern · January 2026. It is an editable US sector proxy applied across history, not a company estimate; foreign reporting currencies also need a currency-specific assessment.
Market prices: Yahoo Finance · BSX, USD. Latest completed close Sep 25, 2026. Price data retrieved Sep 28, 2026.
- ROIC
- NOPAT / average invested capital × 100. NOPAT = operating income × (1 − effective tax rate). Invested capital = equity including noncontrolling interests + debt − cash and equivalents. Average uses period end and one year earlier.
- ROCE
- Operating income / average (assets − current liabilities) × 100, using period end and one year earlier.
- ROIIC
- Year-over-year change in annual/TTM NOPAT / positive year-over-year change in invested capital × 100. Capital reductions and missing inputs yield unavailable values.
- ROE
- Earnings attributable to owners / average equity attributable to owners × 100, using period end and one year earlier.
- ROA
- Net income / average total assets × 100, using period end and one year earlier.
- ROIC − WACC
- ROIC less your WACC assumption, in percentage points. The same scenario rate is applied across history; it is not a reported or historical company WACC.